BioSpace News Archive

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today that it has been granted patent #11,490,966 by the United States Patent and Trademark Office.

The chemiluminescence immunoassays market is expected to increase at a compound annual growth rate (CAGR) of about 7.6% from 2022 to 2030.

The global behavioral health market size is expected to have increased of around USD 279 billion by 2030 and it is expected to grow at an CAGR of 5.02% from 2022 to 2030.

According to Latest Report Study, the clinical trials market was estimated to be worth USD 51.05 billion in 2021 and is anticipated to grow to USD 84.43 billion by 2030, with a CAGR of 5.7% from 2022 to 2030.

Awakn will Partner with Nushama, One of New York’s Leading Ketamine-assisted Therapy Centers

Vancouver, British Columbia--(Newsfile Corp. - November 9, 2022) - Nirvana Life Sciences Inc.(CSE: NIRV) (Nirvana or the “Company”) , a Canadian based life sciences company aimed at developing non-addictive chronic pain and relapse preventing products is pleased to announce the appointment of Mr. Sheldon Inwentash to the Company’s Board of Directors.

AnaptysBio, Inc. announced that Dan Faga, chief executive officer of AnaptysBio, will represent the company in a fireside chat at the Guggenheim 4th Annual Immunology and Neurology Conference on Monday November 14th, 2022, at 1:00 p.m. ET / 10:00 a.m.

BioPorto A/S announced interim financial results for the first nine months of 2022 and business progress for the third quarter of 2022.

TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, announces that the company has opened an office in Boston, to support its increasing US clinical development, partnering and fund-raising activities.

Henry Schein, Inc. announced that the Company will present at the following investor conferences.